TKI Targeted Therapy in Advanced Hepatocellular Cancer
Sort by:
NYU Langone
Common TKI Toxicity Management in 2L HCC Treatment
FEATURING
Jennifer Wu
- 472 views
- May 4, 2023
- 1
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in Unresectable HCC: Where Are We and Where Are We Going?
FEATURING
Daneng Li
- 239 views
- March 7, 2023
- 1
Yale Cancer Center
Hepatocellular Carcinoma - From Screening to Treatment: Current Practice, Pearls, and Puzzles
FEATURING
Tamar Taddei
- 256 views
- February 14, 2023
ecancer
ESMO 2022: Highlights, Commentary, and Analysis of the Key Studies
FEATURING
Bishal Gyawali
- 494 views
- October 3, 2022
- 2
ecancer
ESMO 2022 on the Phase 3 RATIONALE-301 Study: Tislelizumab OS Benefit vs. Sorafenib as 1L Treatment for Unresectable HCC
FEATURING
Richard S. Finn
- 43 views
- September 30, 2022
ecancer
ESMO 2022 on the Phase 3 LEAP-002 Study: Lenvatinib Remains Standard of Care for 1L Therapy in Advanced HCC
FEATURING
Richard S. Finn
- 53 views
- September 30, 2022
Icahn School of Medicine at Mount Sinai
TKI in the Management of Advanced HCC
FEATURING
Augusto Villanueva
- 237 views
- July 7, 2022
University of Colorado Cancer Center
UColorado Updates on Hepatocellular Carcinoma and Biliary Tract Cancers
FEATURING
Lindsey Davis
- 363 views
- April 6, 2022
- 3
Northwell Health
Cabozantinib in Patients With Advanced and Progressing Hepatocellular Carcinoma
FEATURING
Anna Levy
- 162 views
- April 6, 2022
ASCO GI 2022 Conference Coverage
ASCO GI 2022 Updates in HCC
FEATURING
Saeed Sadeghi
- 98 views
- March 11, 2022
CECOG Academy
Updates on Cabozantinib in RCC, HCC, and Thyroid Cancers
FEATURING
Bela Mrinakova
- 169 views
- December 10, 2021
- 1
CECOG Academy
Efficacy of FDA-Approved Lenvatinib in Solid Cancers
FEATURING
Adrian Perdyan
- 46 views
- December 10, 2021
Houston Methodist
Towards a Practical Approach to HCC Management: Focus on Emerging Immunotherapy Role
FEATURING
Ahmed O. Kaseb
- 111 views
- September 23, 2021
Cedars Sinai
Stage C HCC Clinical Data Review: Resin Radioembolization and Kinase Inhibitor Trials
FEATURING
Jorge Marrero,
Willis C. Maddrey
- 192 views
- March 10, 2021